[
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "<5X10^-2",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "10^-2",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "5X10^-3",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "10^-3",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "<=5X10^-4",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "10^-4",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "5X10^-5",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "10^-5",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "5X10^-6",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "10^-6",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "5X10^-7",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(off)",
        "value": "10^-7",
        "unit": "/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(on)",
        "value": ">10^3",
        "unit": "M^-1/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(on)",
        "value": "5X10^3",
        "unit": "M^-1/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(on)",
        "value": "10^4",
        "unit": "M^-1/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    },
    {
        "molecule_name": "antibody of the present invention",
        "protein_target_name": "NgR1 polypeptide",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "k(on)",
        "value": "5X10^4",
        "unit": "M^-1/second",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nOr with dissociation constant K<sub>D</sub>It is less than about 5x10<sup>-2</sup>M, about 10<sup>-2</sup>M, about 5x10<sup>-3</sup>M, about 10<sup>-3</sup>M, about 5x10<sup>-4</sup>M, about 10<sup>-4</sup>M, about 5x10<sup>-5</sup>M, about 10<sup>-5</sup>M, about 5x10<sup>-6</sup>M, about 10<sup>-6</sup>M, about 5x10<sup>-7</sup>M, about 10<sup>-7</sup>M, about 5x10<sup>-8</sup>M, about 10<sup>-8</sup>M, about 5x10<sup>-9</sup>M, about 10<sup>-9</sup>M, about 5x10<sup>-10</sup>M, about 10<sup>-10</sup>M, about 5x10<sup>-11</sup>M, about 10<sup>-11</sup>M, about 5x10<sup>-12</sup>M, about 10<sup>-12</sup>M, about 5x10<sup>-13</sup>M, about 10<sup>-13</sup>M, about 5x10<sup>-14</sup>M, about 10<sup>-14</sup>M, about 5x10<sup>-15</sup>M, about 10<sup>-15</sup>M.\nIn certain embodiments, the antibody of the present invention, its Fab, variant or derivant with less than or etc In 5X10<sup>-2</sup>/ the second, 10<sup>-2</sup>/ the second, 5X10<sup>-3</sup>/ the second or 10<sup>-3</sup>The dissociation rate (k (off)) of/second and NgR1 polypeptide or its fragment or variant Combine.\nAdditionally, the antibody of the present invention, or its Fab, variant or derivant are with less than or equal to 5X10<sup>-4</sup>/ the second, 10<sup>-4</sup>/ the second, 5X10<sup>-5</sup>/ second, or 10<sup>-5</sup>/ second 5X10<sup>-6</sup>/ the second, 10<sup>-6</sup>/ the second, 5X10<sup>-7</sup>/ the second or 10<sup>-7</sup>The dissociation rate (k (off)) of/second Combine with NgR1 polypeptide or its fragment or variant.\nIn other embodiments, the antibody of the present invention, its Fab, variant or derivant with more than or etc In 10<sup>3</sup>M<sup>-1</sup>/ the second, 5X10<sup>3</sup>M<sup>-1</sup>/ the second, 10<sup>4</sup>M<sup>-1</sup>/ second or 5X10<sup>4</sup>M<sup>-1</sup>The association rate (k (on)) of/second and NgR1 polypeptide or its fragment Or variant combines."
    }
]